Children's Mercy Teens With Type 1 Diabetes Will Participate in an Online Peer Support Group.
Part of paid clinical trials in Kansas City, Missouri.
- Sponsor
- Children's Mercy Hospital Kansas City
- Study ID
- NCT06412146
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Years - 19 Years
- Healthy Volunteers
- Accepted
Interventions
- Peer Support Group — BEHAVIORALParticipation in an Online Peer Support Group
Study Details
The goal of this observational study is to examine the impact of an online peer support group in Children's Mercy teens with Type 1 Diabetes. The main objectives are to examine the feasibility and acceptability of the Diabetes Link's online social platform Discord among youth with diabetes as it relates to peer support, diabetes management, and usability and to examine the efficacy/magnitude of the effect of the Discord group on treatment adherence among youth with diabetes. Participants will participate in an online peer support group for 3 months and provide their feedback while doing so.
Key Dates
- Start date
- Jun 21, 2024
- Status verified
- Sep 2025
- Primary completion
- Jan 6, 2025
- Completion
- Jul 14, 2025
Study Design
- Enrollment
- 10 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Peer Support Group
Primary Outcome Measure
Discord User Metrics [ Time Frame: 3 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | - |
Find similar trials in Kansas City, MO
By condition
By specialty
By research site
Related Studies
- Lipoprotein Kinetics in T1DRecruiting · University of Missouri-Columbia · Columbia, Missouri
- Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age FamiliesRecruiting · Nemours Children's Clinic · Jacksonville, Florida
- Registry for Stage 2 Type 1 DiabetesRecruiting · Sanofi · Baltimore, Maryland
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)PHASE1/PHASE2 · Recruiting · COUR Pharmaceutical Development Company, Inc. · Tucson, Arizona